Abstract
The selective removal of impurity proteins and colloidal particles from milk prior to chromatographic purification processes presents a crucial issue in the production of therapeutic proteins from transgenic animals with high recovery yield and purity. We have developed an efficient two-step precipitation method for the recovery of the recombinant human erythropoietin (rhEPO) of interest from transgenic sow milk. Here, rhEPO was partially purified from transgenic sow milk via a two-step precipitation method consisting of ammonium sulfate and divalent metal precipitations, with a yield of approximately 82.1% and a purification fold of 10.4 at a copper concentration of 30 mM. Copper proved to be the strongest flocculating agent among the divalent ions tested for the aggregation of milk proteins under 35%, with ammonium sulfate, zinc, nickel, and calcium demonstrating increasing flocculating capability in the given order. Copper and zinc proved to be appropriate divalent metals for the recovery of rhEPO at high yield and purity, and the optimal concentration ranges of copper and zinc were 20~40 and 40~80 mM, respectively.
Similar content being viewed by others
References
Gordon, J. W., G. A. Scangos, D. J. Plotkin, J. A. Bar-bosa, and F. H. Ruddle (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc. Natl. Acad. Sci. USA 77: 7380–7384.
Choi, Y. S., D. Y. Lee, I. Y. Kim, H. J. Kim, H. W. Park, T. B. Choe, and I. H. Kim (2007) Enhancement of erythropoietin production in recombinant Chinese hamster ovary cells by sodium lactate addition. Biotechnol. Bioprocess Eng. 12: 60–72.
Jo, S. H., S. Y. Kwon, D. S. Park, K. S. Yang, J. W. Kim, K. T. Lee, S. S. Kwak, and H. S. Lee (2006) High-yield production of functional human lactoferrin in transgenic cell cultures of Siberian ginseng (Acantho-panax senticosus). Biotechnol. Bioprocess Eng. 11: 442–448.
Das, R. C. (2001) Production of therapeutic proteins from transgenic animals. Biobusiness 19: 60–64.
Hughes, H. C. (1986) Swine in cardiovascular research. Lab. Anim. Sci. 36: 348–350.
Paleyanda, R. K., W. H. Velander, T. K. Lee, D. H. Scandella, F. C. Gwazdauskas, J. W. Knight, L. W. Hoyer, W. N. Drohan, and H. Lubon (1997) Transgenic pigs produce functional human factor VIII in milk. Nat. Biotechnol. 15: 971–975.
Swanson, M. E., M. J. Martin, J. K. O’Donnell, K. Hoover, W. Lago, V. Huntress, C. T. Parsons, C. A. Pinkert, S. Pilder, and J. S. Logan (1992) Production of functional human hemoglobin in transgenic swine. Biotechnology 10: 557–559.
Velander, W. H., J. L. Johnson, R. L. Page, C. G. Russell, A. Subramanian, T. D. Wilkins, F. C. Gwazdauskas, C. Pittius, and W. N. Drohan (1992) High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C. Proc. Natl. Acad. Sci. USA 89: 12003–12007.
Wall, R. J., V. G. Pursel, A. Shamay, R. A. McKnight, C. W. Pittius, and L. Hennighausen (1991) High-level synthesis of a heterologous milk protein in the mammary glands of transgenic swine. Proc. Natl. Acad. Sci. USA 88: 1696–1700.
Weidle, U. H., H. Lenz, and G. Brem (1991) Genes encoding a mouse monoclonal antibody are expressed in transgenic mice, rabbits and pigs. Gene 98: 185–191.
Kim, H. W. (2007) Engineering blood cells and proteins as blood substitutes: A short review. Biotechnol. Bioprocess Eng. 12: 43–47.
Lappin, T. R., A. P. Maxwell, and P. G. Johnston (2002) EPO’s alter ego: erythropoietin has multiple actions. Stem Cells 20: 485–492.
Park, J. K., Y. K. Lee, P. Lee, H. J. Chung, S. Kim, H. G. Lee, M. K. Seo, J. H. Han, C. G. Park, H. T. Kim, Y. K. Kim, K. S. Min, J. H. Kim, H. T. Lee, and W. K. Chang (2006) Recombinant human erythropoietin produced in milk of transgenic pigs. J. Biotechnol. 122: 362–371.
Toledo, J. R., O. Sanchez, R. M. Segui, G. Garcia, M. Montanez, P. A. Zamora, M. P. Rodriguez, and J. A. Cremata (2006) High expression level of recombinant human erythropoietin in the milk of non-transgenic goats. J. Biotechnol. 123: 225–235.
Nikolov, Z. L. and S. L. Woodard (2004) Downstream processing of recombinant proteins from transgenic feedstock. Curr. Opin. Biotechnol. 15: 479–486.
Morcol, T., Q. He, and S. J. D. Bell (2001) Model process for removal of caseins from milk of transgenic animals. Biotechnol. Prog. 17: 577–582.
Lee, V. W. and K. P. Antonsen (2003) Purification of alpha-1 proteinase inhibitor. US Patent 6,525,176.
Wilkins, T. D. and W. Velander (1992) Isolation of recombinant proteins from milk. J. Cell. Biochem. 49: 333–338.
Degener, A., M. Belew, and W. H. Velander (1998) Zn2+-selective purification of recombinant proteins from the milk of transgenic animals. J. Chromatogr. A 799: 125–137.
Morcol, T. and S. J. D. Bell (2001) Method for processing milk. US Patent 6,183,803.
Bell, S. J. D., T. Morcol, and Q. He (2002) Therapeutic calcium phosphate particles and methods of manufacture and use. US Patent 6,355,271.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, E.G., Lee, S.H., Park, K.M. et al. Efficient recovery of recombinant human erythropoietin from milk of transgenic pigs by two-step pretreatment. Biotechnol Bioproc E 13, 189–196 (2008). https://doi.org/10.1007/s12257-007-0158-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-007-0158-x